ବାୱେଲ୍ (କୋଲୋରେକ୍ଟାଲ୍) କ୍ୟାନ୍ସର

The goal of this clinical trial is to evaluate whether Nuvastatic can reduce cancer-related fatigue in adult patients with colon cancer undergoing first-line chemotherapy. The main questions it aims to answer are: Does Nuvastatic significantly reduce cancer-related fatigue compared to placebo? Is Nuvastatic safe and well tolerated in this patient population? Researchers will compare Nuvastatic vs placebo to see if Nuvastatic improves fatigue scores and maintains an acceptable safety profile. Participants will: Receive Nuvastatic or placebo sachets (3 times per day) for 3 cycles of 20 days…

ସ୍ପୋନ୍ସର: ନେଚରସିଉଟିକାଲ୍ସ ଏସଡିଏନ ବିଏଚଡି
କ୍ଲିନିକାଲ୍ ଟ୍ରାଏଲ୍ସ.ଗୋଭ ରେ NCT07669519
ରେଜିଷ୍ଟ୍ରିରେ ଶେଷ ଅପଡେଟ୍ 25 ଅଗଷ୍ଟ 2026 · ଆମ ଦ୍ୱାରା ପଠନ 20 ଅକ୍ଟୋବର 2026